Plain-English translation of NCT05868928 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying special MRI scans to create a scoring system that predicts whether brain cancer will come back after stereotactic radiosurgery (a focused radiation treatment). Researchers will collect detailed imaging information from patients before and after their radiation treatment to see if certain scan patterns can warn doctors about the risk of cancer returning or radiation damage to healthy brain tissue.
Currently, doctors have limited ways to predict which patients will have their cancer return after radiation treatment or develop damage from the radiation itself. This study aims to solve that problem by developing an imaging-based tool that could help doctors better plan follow-up care and catch recurrences earlier.
You will receive your stereotactic radiosurgery treatment as planned, and then have detailed MRI scans done every 3 months after treatment. These special MRI scans take standard images plus additional advanced imaging to provide detailed information about your brain tissue. The study will track your imaging results for as long as follow-up care is recommended to see if the scan patterns can predict cancer recurrence or radiation-related complications.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
South Korea
Sponsor
Asan Medical Center
Enrollment target
~132 participants
Started
December 2023
Primary completion
July 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ho Sung Kim, MD, PhD
Asan Medical Center